Effects of bifidobacterial cytoplasm peptide and protein fractions on mouse lymphocyte proliferation and cytokine production

Food and Agricultural Immunology

Volumn 17, Issue 1, 2006, Pages 29-42

  Amrouche, T ^a,b,c   Boutin, Y ^b,d   Fliss, I ^a,b  

^a UNIVERSITÉ LAVAL   (Canada)

^b LAVAL UNIVERSITY   (Canada)

^c Department of Food Technology

^d TransBiotech   (Canada)

Author keywords

Bifidobacteria; Cytokines; Cytoplasm; Peptides; Proteins; Splenocyte proliferation

Indexed keywords

BIFIDOBACTERIUM ANIMALIS; MURINAE;

EID: 33645067905     PISSN: 09540105     EISSN: 14653443     Source Type: Journal    
DOI: 10.1080/09540100600565895     Document Type: Article

References (52)

1. Aaron ART, Canaday DH, Henry Boom W, Harding CV. 2004. Bacterial heat shock proteins Promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. J Immunol 172:5277-5286.
2. Amrouche T, Boutin Y, Prioult G, Fliss I. 2006. Effects of bifidobacterial cytoplasm, cell wall and exopolysaccharides on mouse lymphocyte proliferation and cytokine production. Int Dairy J 16:70-80.
3. Ang DK, Libereck D, Skowyra MZ, Georgopoulos C. 1991. Biological role and regulation of the universally conserved heat shock proteins. J Biological Chem 266:24233-24236.
4. Arbour N, Tremblay P, Oth D. 1996. N-formyl-methionyl-leucyl- phenylalanine induces and modulates IL-1 and IL-6 in human PBMC. Cytokine 8:468-475.
5. Baek SH, Seo JK, Chae CB, Suh PG, Ryu SH. 1996. Identification of the peptides that stimulate the phosphoinositide hydrolysis in lymphocyte cell lines from peptide libraries. J Biological Chem 271:8170-8175.
6. Bot A, Smith KA, Von Herrath M. 2004. Molecular and Cellular Control of T1/T2 Immunity at the interface between antimicrobial defense and immune pathology. DNA Cell Biol 23:341-350.
7. Castellino F, Boucher PE, Eichelberg K, Mayhew M, Rothman JE, Houghton AN, Germain RN. 1999. Receptor-mediated uptake of antigen/heat shock protein complexes results in major histocompatibility complex class I antigen presentation via two distinct processing pathways. J Experim Med 191:1957-1964.
8. Chadwick VS, Mellor DM, Myers DB, Selden AC, Keshavarzian A, Broom MF, Hobson CH. 1988. Production of peptides inducing chemotaxis and lysosomal enzyme release in human neutrophils by intestinal bacteria in vitro and in vivo. Scand J Gastroenterol 23:121-128.
9. Champomier-Verges MC, Maguin E, Mistou MY, Anglade P, Chich JF. 2002. Lactic acid bacteria and proteomics: Current knowledge and perspectives. J Chromatography 771:329-342.
10. Christensen HR, Frokiaer H, Pestka JJ. 2002. Lactobacilli differentially modulate expression of cytokines and maturation surface markers in murine dendritic cells. J Immunol 168:171-178.
11. Chua-Intra B, Peerapakorn S, Davey N, Jurcevic S, Busson M, Vordermeier HM, Pirayavaraporn C, Ivanyi J. 1998. T-cell recognition of mycobacterial GroES peptides in Thai leprosy patients and contacts. Infect Immun 66:4903-4909.
12. Chukeatirote E. 2003. Potential use of probiotics. Songklanakarin. J Sci Technol 25:275-282.
13. De Angelis M, Di Cagno R, Huet C, Crecchio C, Fox PF, Gobbetti M. 2004. Heat shock response in Lactobacillus plantarum. Appl Environ Microbiol 70:1336-1346.
14. Dobrotina NA, Ezhova GP, Kazatskaia ZA, Ladygina GN, Kurova MV. 1992. The comparative characteristics of the biological and immunomodulating activities of enzyme preparations of microbial origin. Nauchnye Doki Vyss Shkoly Biol Nauki 2:90-96.
15. Ernst S, Lange C, Wilbers A, Goebeler V, Gerke V, Rescher U. 2004. An annexin 1 N-terminal peptide activates leukocytes by triggering different members of the formyl peptide receptor family. 1. J Immunol 172:7669-7676.
16. Fernandez-Espla M, Garault P, Monnet V, Rul F. 2000. Streptococcus thermophilus cell wall-anchored proteinase: Release, purification, and biochemical and genetic characterization. Appl Environ Microbiol 66:4772-4778.
17. Freer RJ, Day AR, Muthukumaraswamy N, Pinon D, Wu A, Showell HJ, Becker EL. 1982. Formyl peptide chemoattractants: A model of the receptor on rabbits neutrophils. Biochemistry 21:257-263.
18. Fu H, Dahlgren C, Bylund J. 2003. Subinhibitory concentrations of the deformylase inhibitor actinonin increase bacterial release of neutrophil-activating peptides: A new approach to antimicrobial chemotherapy. Antimicrob Agents Chemother 47:2545-2550.
19. Groleau PE, Jimenez-Flores R, Gauthier SF, Pouliot Y. 2002. Fractionation of beta-lactoglobulin tryptic peptides by ampholyte-free isoelectric focusing. J Agric Food Chem 50:578-583.
20. Hobson CH, Roberts EC, Broom MF, Mellor DM, Sherriff RM, Chadwick VS. 1990. Radio-immunoassay for formyl methionyl leucyl phenylalanine. I. Development and application to assessment of chemotactic peptide production by enteric bacteria. J Gastroenterol Hepatol 5:32-37.
21. Houba V, Berger FM, Dinarello CA, Johnson AG, Le J, Mauel J, Van der Meer JW, Philippeaux MM, Vilcek J, Vogels MT. 1992. Protodyne: An immunostimulatory protein component, prepared from gram-positive Bacillus subtilis. Develop Biologic Standardiz 77:121-128.
22. Hussain R, Shahid F, Zafar S, Dojki M, Dockrell HM. 2004. Immune profiling of leprosy and tuberculosis patients to 15-mer peptides of Mycobacterium leprae and M. tuberculosis GroES in a BCG vaccinated area: Implications for development of vaccine and diagnostic reagents. Immunology 111:462-471.
23. Iliev ID, Kitazawa H, Shimosato T, Katoh S, Morita H, He F, Hosoda M, Saito T. 2005. Strong immunostimulation in murine immune cells by Lactobacillus rhamnosus GG DNA containing novel oligodeoxynucleotide pattern. Cellular Microbiol 7:403-414.
24. Kankaanpa P, Su tasb Y, Salminena S, Isolaurib E. 2003. Homogenates derived from probiotic bacteria provide down-regulatory signals for peripheral blood mononuclear cells. Food Chem 83:269-277.
25. Kim Y, Bae YS, Park JC, Suh PG, Ryu SH. 2001. The synthetic peptide, His-Phe-Tyr-Leu-Pro-Met, is a chemoattractant for Jukat T cells. Experim Molec Med 33:257-262.
26. Laas T. 1998. Isoelectric focusing. In: Janson J-C, Ryden L, editors. Protein purification. Toronto, Canada: Wiley. p 495.
27. Laemmli UK. 1970. Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 22:680-685.
28. Lancaster M, Fields RD 1996. Antibiotic and cytotoxic drug susceptibility assays using resazurin and poising agents. US patent #5501959.
29. Le Y, Murphy PM, Wang JM. 2002. Formyl-peptide receptors revisited. Trends Immunol 23:541-548.
30. Lee JW, Shin JG, Kim EH, Kang HE, Yim IB, Kim JY, Joo HG, Woo HJ. 2004. Immunomodulatory and antitumor effects in vivo by the cytoplasmic fraction of Lactobacillus casei and Bifidobacterium longum. J Veterinary Sci 5:41-48.
31. Marasco WA, Phan SH, Krutzsch H, Showell HJ, Feltner DE, Nairnll Becker REL, Ward PA. 1984. Purification and identification of formyl-methionyl-leucyl- phenylalanine as the major peptide neutrophil chemotactic factor produced by Escherichia coli. J Biological Chem 259:5430-5439.
32. Mastrandrea F, Coradduzza G, Serio G, Minardi A, Manelli M, Ardito S, Muratore L. 2004. Probiotics reduce the CD34+ hemopoietic precursor cell increased traffic in allergic subjects. Allergy Immunol (Paris) 36:118-122.
33. McCarthy J, O'Mahony L, O'Callaghan L, Sheil B, Vaughan EE, Fitzsimons N, Fitzgibbon J, O'Sullivan GC, Kiely B, Collins JK, Shanahan F. 2003. Double blind, placebo controlled trial of two probiotic strains in interleukin 10 knockout mice and mechanistic link with cytokine balance. Gut 52:975-980.
34. Nouaille S, Ribeiro LA, Miyoshi A, Pontes D, Le Loir Y, Costa Oliveira S, Langella P, Azevedo V. 2003. Heterologous protein production and delivery systems for Lactococcus lactis. Genetics Molec Res 2:102-111.
35. Panaro MA, Mitolo V. 1999. Cellular responses to FMLP challenging: A mini-review. Immunopharmacol Immunotoxicol 21:397-419.
36. Prasad J, McJarrow P, Gopal P. 2003. Heat and osmotic stress responses of probiotic Lactobacillus rhamnosus HN001 (DR20) in relation to viability after drying. Appl Environ Microbiol 69:917-925.
37. Prioult G, Fliss I, Pecquet S. 2003. Effect of probiotic bacteria on induction and maintenance of oral tolerance to β-Lactoglobulin in gnotobiotic mice. Clinic Diagnost Lab Immunol 10:787-792.
38. Reid G, Siang Gan B, She YM, Ens W, Weinberger S, Howard JC. 2002. Rapid identification of probiotic Lactobacillus biosurfactant proteins by protein chip tandem mass spectrometry tryptic peptide sequencing. Appl Environ Microbiol 68:977-980.
39. Schiffmann E, Showell HJ, Corcoran BA, Ward PA, Smith E, Becker EL. 1975. The isolation and partial characterization of neutrophil chemotactic factors from Escherichia coli. J Immunol 114:1831-1837.
40. Spellberg B, Edwards JE. 2001. Type 1/Type 2 immunity in infectious diseases. Clinical Infect Dis 32:76102.
41. Sreekumar O, Hosono A. 1998. The antimutagenic properties of a polysaccharide produced by Bifibobacterium longum and its cultured milk against some heterocyclic amines. Canad J Microbiol 44:1029-1036.
42. Svensson L, Dahlgren C, Wenneras C. 2002. The chemoattractant Trp-Lys-Tyr-Met-Val-D-Met activates eosinophils through the formyl peptide receptor and one of its homologues, formyl peptide receptor-like 1. J Leukocyte Biol 72:810-818.
43. Tejada-Simon MV, Pestka JJ. 1999. Proinflammatory cytokine and nitric oxide induction in murine macrophages by cell wall and cytoplasmic extracts of lactic acid bacteria. J Food Protect 62:1435-1444.
44. Tobian AA, Canaday DH, Boom WH, Harding CV. 2004. Bacterial heat shock proteins promote CD91-dependent class I MHC cross-presentation of chaperoned peptide to CD8+ T cells by cytosolic mechanisms in dendritic cells versus vacuolar mechanisms in macrophages. J Immunol 172:5277-5286.
45. Touré R, Kheadr E, Lacroix C, Moroni O, Fliss I. 2003. Production of antibacterial substances by bifidobacterial isolates from infant stool active against Listeria monocytogenes. J Appl Microbiol 95:1058-1069.
46. Valentini G, Baroni A, Esposito K, Naclerio C, Buommino E, Farzati A, Cuomo G, Farzati B. 2001. Peripheral blood T lymphocytes from systemic sclerosis patients show both Th1 and Th2 activation. J Clin Immunol 21:210-217.
47. Vinderola CG, Medici M, Perdigon G. 2004. Relationship between interaction sites in the gut, hydrophobicity, mucosal immunomodulating capacities and cell wall protein profiles in indigenous and exogenous bacteria. J Appl Microbiol 96:230-243.
48. von Heijne G. 1990. The signal peptide. J Membrane Biol 115:195-201.
49. Wang PH, Hsu CI, Tang SC, Huang YL, Lin JY, Ko JL. 2004. Fungal immunomodulatory protein from Flammulina velutipes induces interferon-gamma production through p38 mitogen-activated protein kinase signaling pathway. J Agric Food Chem 52:2721-2725.
50. Ward PA, Lepow IH, Newman LJ. 1968. Bacterial factors chemotactic for polymorphonuclear leukocytes. Am J Pathol 52:725-736.
51. Yazdanbakhsh M, Rodrigues LC. 2001. Allergy and the hygiene hypothesis: The Th1/Th2 counter regulation cannot provide an explanation. Wiener Klinische Wochenschrift 113:899-902.
52. Zachariae CO, Jinquan T, Nielsen V, Kaltoft K, Thestrup-Pedersen K. 1992. Phenotypic determination of T-lymphocytes responding to chemotactic stimulation from fMLP, IL-8, human IL-10, and epidermal lymphocyte chemotactic factor. Arch Dermatol Res 284:333-338.